The company says Galway, Ireland-based Ridgeback’s offerings enhance its full-service portfolio of minimally invasive medical devices. The company provides end-to-end manufacturing solutions for such devices and now adds customized balloon catheter solutions to its offerings.
“The acquisition of the Ridgeback team is a significant milestone in our strategic growth plan,” said Alex Wallstein, Quasar CEO. “Ridgeback’s innovative balloon technology fills a critical gap in Quasar’s capabilities plus expands our footprint to Galway, Ireland, with its vibrant med-tech community. We welcome the Ridgeback team to our Quasar family.”
Ridgeback specializes in rapid turn-around and innovative balloon design. It offers bladed, perfusion and multi-lumen balloons for a variety of procedures across structural heart, cardiovascular, neurovascular and peripheral interventions.
The acquisition adds extensive on-site capabilities, rapid lead-times for high-quality catheter types and quality and assurance, Quasar said.
“Joining Quasar Medical marks an exciting new chapter for the Ridgeback team,” said Ray Blowick, CEO of Ridgeback Technologies. “We have recently moved to a new 4,500-square-foot site to support further growth, and I am excited to leverage Quasar’s mass production set-up, adding scale-up to our front-end design and development expertise.”
